| Symbol |
Name |
|
A2ML1
|
alpha-2-macroglobulin-like 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ADRB1
|
adrenoceptor beta 1
|
|
AGR2
|
anterior gradient 2
|
|
AIRE
|
autoimmune regulator
|
|
AKAP3
|
A kinase (PRKA) anchor protein 3
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
ALB
|
albumin
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ANKRD30A
|
ankyrin repeat domain 30A
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA2
|
annexin A2
|
|
APOA1
|
apolipoprotein A-I
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
BCAM
|
basal cell adhesion molecule (Lutheran blood group)
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCR
|
breakpoint cluster region
|
|
BCRP1
|
breakpoint cluster region pseudogene 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRD3
|
bromodomain containing 3
|
|
BSG
|
basigin (Ok blood group)
|
|
C1GALT1C1
|
C1GALT1-specific chaperone 1
|
|
C2
|
complement component 2
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD164
|
CD164 molecule, sialomucin
|
|
CD19
|
CD19 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD1B
|
CD1b molecule
|
|
CD1C
|
CD1c molecule
|
|
CD1D
|
CD1d molecule
|
|
CD1E
|
CD1e molecule
|
|
CD2
|
CD2 molecule
|
|
CD209
|
CD209 molecule
|
|
CD22
|
CD22 molecule
|
|
CD24
|
CD24 molecule
|
|
CD27
|
CD27 molecule
|
|
CD28
|
CD28 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD6
|
CD6 molecule
|
|
CD63
|
CD63 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD80
|
CD80 molecule
|
|
CD83
|
CD83 molecule
|
|
CD86
|
CD86 molecule
|
|
CD96
|
CD96 molecule
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CLEC12A
|
C-type lectin domain family 12, member A
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CLEC9A
|
C-type lectin domain family 9, member A
|
|
CNBP
|
CCHC-type zinc finger, nucleic acid binding protein
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTAGE1
|
cutaneous T-cell lymphoma-associated antigen 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTSS
|
cathepsin S
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEAF1
|
DEAF1 transcription factor
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DUSP12
|
dual specificity phosphatase 12
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL4
|
ELAV like neuron-specific RNA binding protein 4
|
|
ENO1
|
enolase 1, (alpha)
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERMAP
|
erythroblast membrane-associated protein (Scianna blood group)
|
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
|
FAS
|
Fas cell surface death receptor
|
|
FCAR
|
Fc fragment of IgA receptor
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FUT1
|
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FUT5
|
fucosyltransferase 5 (alpha (1,3) fucosyltransferase)
|
|
GAB3
|
GRB2-associated binding protein 3
|
|
GATA3
|
GATA binding protein 3
|
|
GCNT2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)
|
|
GLDN
|
gliomedin
|
|
GP2
|
glycoprotein 2 (zymogen granule membrane)
|
|
GYPA
|
glycophorin A (MNS blood group)
|
|
GYPB
|
glycophorin B (MNS blood group)
|
|
GYPC
|
glycophorin C (Gerbich blood group)
|
|
HFE
|
hemochromatosis
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DOA
|
major histocompatibility complex, class II, DO alpha
|
|
HLA-DOB
|
major histocompatibility complex, class II, DO beta
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HNRNPDL
|
heterogeneous nuclear ribonucleoprotein D-like
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGL
|
immunoglobulin lambda locus
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
INHBA
|
inhibin, beta A
|
|
INS
|
insulin
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
KDM5B
|
lysine (K)-specific demethylase 5B
|
|
KDR
|
kinase insert domain receptor
|
|
KEL
|
Kell blood group, metallo-endopeptidase
|
|
KIAA0020
|
KIAA0020
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT1
|
keratin 1, type II
|
|
KRT18
|
keratin 18, type I
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LAPTM5
|
lysosomal protein transmembrane 5
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LOC100289290
|
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LY6K
|
lymphocyte antigen 6 complex, locus K
|
|
MAGEA11
|
melanoma antigen family A11
|
|
MAGEA12
|
melanoma antigen family A12
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAGEA6
|
melanoma antigen family A6
|
|
MAGEA9
|
melanoma antigen family A9
|
|
MAGEB1
|
melanoma antigen family B1
|
|
MAGEB2
|
melanoma antigen family B2
|
|
MAGEC1
|
melanoma antigen family C1
|
|
MAGEC2
|
melanoma antigen family C2
|
|
MAN2C1
|
mannosidase, alpha, class 2C, member 1
|
|
MAP2
|
microtubule-associated protein 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MARVELD2
|
MARVEL domain containing 2
|
|
MGC16025
|
uncharacterized LOC85009
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MIRLET7I
|
microRNA let-7i
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MLANA
|
melan-A
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC3A
|
mucin 3A, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFASC
|
neurofascin
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
OSM
|
oncostatin M
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PAX5
|
paired box 5
|
|
PDCD1
|
programmed cell death 1
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PF4
|
platelet factor 4
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
|
PLAC1
|
placenta-specific 1
|
|
PLAT
|
plasminogen activator, tissue
|
|
PMEL
|
premelanosome protein
|
|
PMPCB
|
peptidase (mitochondrial processing) beta
|
|
PMS1
|
PMS1 postmeiotic segregation increased 1 (S. cerevisiae)
|
|
PNPT1
|
polyribonucleotide nucleotidyltransferase 1
|
|
PODXL
|
podocalyxin-like
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRM2
|
protamine 2
|
|
PROM1
|
prominin 1
|
|
PRTN3
|
proteinase 3
|
|
PSAP
|
prosaposin
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
RAB38
|
RAB38, member RAS oncogene family
|
|
RCHY1
|
ring finger and CHY zinc finger domain containing 1, E3 ubiquitin protein ligase
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RHCE
|
Rh blood group, CcEe antigens
|
|
RHD
|
Rh blood group, D antigen
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
RPL10A
|
ribosomal protein L10a
|
|
RPS2
|
ribosomal protein S2
|
|
SAG
|
S-antigen; retina and pineal gland (arrestin)
|
|
SELL
|
selectin L
|
|
SEPSECS
|
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SIGLEC1
|
sialic acid binding Ig-like lectin 1, sialoadhesin
|
|
SLC14A1
|
solute carrier family 14 (urea transporter), member 1 (Kidd blood group)
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SPA17
|
sperm autoantigenic protein 17
|
|
SPANXC
|
SPANX family, member C
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
|
ST8SIA5
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
TBCE
|
tubulin folding cofactor E
|
|
TBX21
|
T-box 21
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TP53
|
tumor protein p53
|
|
TPO
|
thyroid peroxidase
|
|
TRB
|
T cell receptor beta locus
|
|
TRIM21
|
tripartite motif containing 21
|
|
TTK
|
TTK protein kinase
|
|
VCX
|
variable charge, X-linked
|
|
VCY
|
variable charge, Y-linked
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WT1
|
Wilms tumor 1
|
|
YBX1
|
Y box binding protein 1
|
